2016 American Transplant Congress
The Use of Perioperative Lactate Values as Markers for Adverse Outcomes in Liver Transplantation.
Introduction:We examined the utility of perioperative lactate values for the prediction of multiple post-transplant outcomes including length of hospital stay (LOS), acute cellular rejection (ACR),…2016 American Transplant Congress
Left Renal Vein Ligation for Management of Portal Hypoperfusion in Liver Transplantation.
Henry Ford Transplant Institute, Henry Ford Hospital, Detroit, MI.
Intro: In orthotopic liver transplant (OLT), low portal venous flow (PVF) is an independent risk factor for 1-year mortality. Ligation of existing portosystemic shunts is…2016 American Transplant Congress
Stress Cardiomyopathy in the Perio-Perative Period After Liver Transplant.
Purpose: Stress cardiomyopathy is a pathological condition in which excess catecholamines leading to cardiac dysfunction. This phenomenon is associated with troponin elevation, EKG changes, and…2016 American Transplant Congress
Predictive Factors of Early Hospital Readmission in Liver Transplant Recipients.
Pharmacy, Rush University Medical Center, Chicago, IL.
Early hospital readmission post liver transplant, defined as within 30 days of discharge from the same facility, is associated with increased morbidity, mortality, as well…2016 American Transplant Congress
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.
Purpose: Cardiovascular (CV) events remain a major source of morbidity and mortality following liver transplantation (LT). This review evaluates the incidence of and risk assessment…2016 American Transplant Congress
Review of Aborted Hepatectomy of Liver Transplantation in a Single Center Study.
General Surgery, Samsung Medical Center, Seoul, Korea.
Liver transplantation (LT) has become a popular option for the treatment of endstage hepatic failure. More attention has been given to donor safety, but still…2016 American Transplant Congress
Outcomes of Anticoagulation Use for Portal Vein Thrombosis in University of Wisconsin Liver Transplant Patients.
Background: The prevalence of Portal Vein Thrombosis (PVT) in cirrhotic liver transplant patients increases the risk of morbidity and mortality post-liver transplantation. Current research suggests…2016 American Transplant Congress
Outcomes Following Inguinal Hernia Repair in Liver Transplant Recipients.
Surgery, Johns Hopkins, Baltimore.
Liver transplant (LT) recipients are assumed to have poor outcomes following general surgical procedures, which may be a reason why most are directed to transplant…2016 American Transplant Congress
National Trends of Acute Myocardial Infarction and Percutaneous Interventions in Liver Transplant Hospitalizations from 2006-2012.
RMTI, Icahn School of Medicine at Mount Sinai, New York, NY.
Introduction: Kidney transplantation has been associated with increased cardiovascular risk but the national epidemiology of acute myocardial infarctions (AMI) and percutaneous interventions (PCI) has not…2016 American Transplant Congress
Intra-Operative Hepatic Arterial Flow Predicts Hepatic Artery Complications After Deceased Donor Liver Transplantation.
Baylor University, Dallas, TX.
IntroductionHepatic arterial flow (HAF) is important for post liver transplant outcomes. This study was conducted to determine the predictive value of measured intraoperative HAF on…
American Transplant Congress abstracts